Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31019979 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL10948340 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| Ammonia Solution, Strong SCHEMBL1230492 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL371443 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL2131856 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL15327010 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| Ammonia Solution, Strong SCHEMBL3684746 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL28763748 | 0.97 | TP53 (0.44) | TP53ALDH1A1TSHRSMN1; SMN2LMNA | |
| Ammonia Solution, Strong SCHEMBL4642221 | 0.94 | TP53 (0.42) | TP53ALDH1A1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL9055914 | 0.94 | TP53 (0.42) | TP53ALDH1A1TSHRSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074674-A | Double-modified dietary fiber-based sugar-control health food and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094649-A | Personal care compositions | — | 2026-05-26 | — | — | CN | claimed |
| EP-3318549-B1 | METHOD OF MAKING ACRYLIC ACID FROM HYDROXYPROPIONIC ACID | PROCTER & GAMBLE (US) | 2025-12-10 | — | — | EP | claimed |
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | UNIVERZITA PARDUBICE (CZ) | 2025-06-24 | — | — | US | claimed |
| CN-119792105-A | Powder composition for finishing make-up and preparation method thereof | 浙江雅颜生物科技股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-3129346-B1 | BIOMASS PROCESSING METHOD | SAPPI BIOTECH UK LTD (GB) | 2025-03-19 | — | — | EP | claimed |
| US-12239679-B1 | Antibacterial modified chitosan-based hemostatic material and method of manufacturing the same | Xuan Ho, Vien Anh (VN) | 2025-03-04 | — | — | US | claimed |
| CN-119385863-A | Preparation method and application of amphiphilic oil agent for skin care product | 宁波大医本源生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-115867145-B | Stable liquid animal feed ingredients | 普拉克生化公司 | 2024-12-20 | — | — | CN | claimed |
| US-12139581-B2 | Polyamic acid composition for packaging electronic components, and method for packaging electronic components using same | PI ADVANCED MATERIALS CO., LTD. (KR) | 2024-11-12 | — | — | US | claimed |
| US-5877212-A | HYDROGEN BONDING WITH COMPLEXING AGENT | YU RUEY J (US) | 1999-03-02 | — | — | US | claimed |
| WO-1998046217-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 1998-10-22 | — | — | WO | claimed |
| US-5811112-A | LEAVE-ON SKIN CARE PRODUCT; TREATMENT OF DRYNESS, WRINKLING | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO INC. (US) | 1998-09-22 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0671162-A2 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1995-09-13 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| US-4863506-A | Methods for regulating the growth of plants and growth regulant compositions | UNION OIL COMPANY OF CALIFORNIA (US) | 1989-09-05 | — | — | US | claimed |
| EP-0241568-A1 | Methods for regulating the growth of plants and growth regulant compositions | UNION OIL COMPANY OF CALIFORNIA (US) | 1987-10-21 | — | — | EP | claimed |
| US-4021572-A | Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates | SCOTT EUGENE J VAN | 1977-05-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | HRH2, LDHA, HCAR2 | TP53 2201/4885ALDH1A1 554/4885TSHR 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.